share_log

Summit Healthcare Acquisition (SMIH) Vs. Its Rivals Critical Contrast

Summit Healthcare Acquisition (SMIH) Vs. Its Rivals Critical Contrast

峰會醫療收購 (SMIH) Vs.競爭對手的關鍵對比
Defense World ·  2022/12/15 01:12

Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it compare to its competitors? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

頂峰醫療收購(納斯達克:SMIH-GET評級)是710家上市公司之一,但與競爭對手相比,它的表現如何?我們將根據收購的機構所有權、分析師建議、估值、盈利能力、收益、股息和風險,將Summit Healthcare收購與類似公司進行比較。

Volatility and Risk

波動性和風險

Summit Healthcare Acquisition has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, indicating that their average stock price is 95% less volatile than the S&P 500.

Summit Healthcare收購的貝塔係數為0.01,表明其股價的波動性比標準普爾500指數低99%。相比之下,Summit Healthcare收購的競爭對手的貝塔係數為0.05,這表明它們的平均股價波動性比標準普爾500指數低95%。

Get
到達
Summit Healthcare Acquisition
Summit Healthcare收購
alerts:
警報:

Profitability

盈利能力

This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.

此表比較了Summit Healthcare收購及其競爭對手的淨利潤率、股本回報率和資產回報率。

Net Margins Return on Equity Return on Assets
Summit Healthcare Acquisition N/A 46.53% 8.78%
Summit Healthcare Acquisition Competitors 11.67% -68.35% 2.51%
淨利潤率 股本回報率 資產回報率
Summit Healthcare收購 不適用 46.53% 8.78%
Summit Healthcare收購競爭對手 11.67% -68.35% 2.51%

Insider & Institutional Ownership

內部人與機構所有權

64.3% of shares of all "Holding & other investment offices" companies are owned by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
所有“控股及其他投資辦事處”公司64.3%的股份由機構投資者持有。所有“控股及其他投資辦事處”公司17.6%的股份由公司內部人士持有。強大的機構持股表明,對沖基金、捐贈基金和大型基金管理公司相信,一家公司有望實現長期增長。

Valuation and Earnings

估值和收益

This table compares Summit Healthcare Acquisition and its competitors top-line revenue, earnings per share (EPS) and valuation.

此表比較了Summit Healthcare收購及其競爭對手的營收、每股收益(EPS)和估值。

Gross Revenue Net Income Price/Earnings Ratio
Summit Healthcare Acquisition N/A -$550,000.00 12.51
Summit Healthcare Acquisition Competitors $1.72 billion $88.36 million 25.06
總收入 淨收入 本益比
Summit Healthcare收購 不適用 -$550,000.00 12.51
Summit Healthcare收購競爭對手 17.2億美元 8836萬美元 25.06

Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summit Healthcare收購的競爭對手的收入和收益都高於Summit Healthcare收購。Summit Healthcare收購的本益比低於競爭對手,這表明它目前比行業內的其他公司更負擔得起。

Analyst Recommendations

分析師建議

This is a summary of current ratings for Summit Healthcare Acquisition and its competitors, as reported by MarketBeat.

據MarketBeat報道,這是Summit Healthcare Acquisition及其競爭對手目前的評級摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Summit Healthcare Acquisition 0 0 0 0 N/A
Summit Healthcare Acquisition Competitors 113 592 886 18 2.50
銷售評級 保持評級 購買評級 強勁的買入評級 評級分數
Summit Healthcare收購 0 0 0 0 不適用
Summit Healthcare收購競爭對手 113 592 886 18 2.50

As a group, "Holding & other investment offices" companies have a potential upside of 65.14%. Given Summit Healthcare Acquisition's competitors higher probable upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.

作為一個整體,“控股和其他投資辦公室”公司有65.14%的潛在上行空間。考慮到Summit Healthcare收購的競爭對手更有可能上行,分析師顯然認為Summit Healthcare收購的增長方面不如競爭對手有利。

Summary

摘要

Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.

Summit Healthcare收購的競爭對手在比較的10個因素中有8個擊敗了Summit Healthcare收購。

About Summit Healthcare Acquisition

關於Summit Healthcare收購

(Get Rating)

(獲取評級)

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Summit Healthcare Acquisition Corp.沒有重大業務。擬與一個或者多個企業或者實體進行合併、換股、資產收購、股份購買、重組或者類似的業務合併。該公司成立於2020年,總部設在香港中環。

Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

收到Summit Healthcare收購日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Summit Healthcare收購和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論